Roche scru­ti­nized by UK watch­dog over 'mis­lead­ing' Ro­z­lytrek pro­mo­tion­al web­site

The UK’s Pre­scrip­tion Med­i­cines Code of Prac­tice Au­thor­i­ty (PM­C­PA) has ruled that a Roche web­page for its can­cer med­ica­tion Ro­z­lytrek mis­led health­care pro­fes­sion­als.

The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER